Central Trust Co (CTTC) 0.2450 $CTTC
SeeThruEquity Initiates Coverage on Competitive Technologies (OTCQX:CTTC) with a Speculative Buy Rating - Video Research Alert on InvestmentPitch.com
Thomson Reuters ONE - Thu Jul 03, 9:36AM CDT
Vancouver, BC, July 3, 2014 - New York-based SeeThruEquity has initiated coverage on Competitive Technologies (OTCQX:CTTC). Analyst Brandon Primack gives the company a speculative buy rating, and a target price of $0.79, a premium of 147% to the $0.32 price on June 26th, the day the report was issued.
Judge Ruling Favors Calmare® Pain Therapy Reimbursement In Personal Injury Case Against Allstate Insurance Co.
PR Newswire - Mon Jun 30, 8:32AM CDT
The Calmare® Pain Therapy Device, the flagship product of Competitive Technologies, Inc., (OTCQX: CTTC) (CTI), the pain mitigation company, gained a favorable reimbursement ruling from the New York City Civil Courts in a personal injury case against Allstate Insurance, Co., (Allstate). In the ruling, the Court instructed the insurance giant to reimburse Forest Rehabilitation Medicine P.C. (Forest) for its use of Calmare pain therapy (Calmare) on patients who suffer pain as a result of car accident injuries.
SeeThruEquity Initiates Research Coverage on Competitive Technologies Inc. with Target Price of $0.79
ACCESSWIRE - Thu Jun 26, 8:02AM CDT
New York, NY / ACCESSWIRE / June 26, 2014 / SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced that it has initiated coverage on Competitive Technologies Inc. (OTCQX: CTTC), a pain mitigation company with innovative wound and pain management products and technologies.
Competitive Technologies' Calmare® Pain Therapy Device Featured On The Emmy® Award Winning Program "The Doctors"
PR Newswire - Wed Jun 11, 8:00AM CDT
Competitive Technologies, Inc., (OTCQX: CTTC) (CTI) the pain mitigation company, today announced that the Emmy® award winning TV program "The Doctors" recently featured a medical case involving a young patient living with Complex Regional Pain Syndrome (CRPS) - a long-term chronic disease characterized by severe chronic pain, swelling, and changes in the skin that often worsens over time.
Competitive Tech Slated To Present At The LD MICRO Fourth Invitational Conference
PR Newswire - Mon Jun 02, 9:39AM CDT
Competitive Technologies, Inc., (OTCQX: CTTC) (CTI) the pain mitigation company, will present at LD MICRO's 4th Invitational Conference on Wednesday, June 4, 2014, at 1:30 PM PDT / 4:30 PM EDT.
Competitive Technologies Signs Letter Of Intent To Distribute Calmare With The Mediterranean For Integration And Technology
PR Newswire - Wed May 28, 12:00PM CDT
Competitive Technologies, Inc., (OTCQX: CTTC) (CTI), today announced the signing of a binding letter of intent to distribute and sell the Calmare® Pain Therapy devices (Calmare) exclusively throughout the Middle East and North African territories with The Mediterranean for Integration and Technology (Mediterranean), to distribute and sell Calmare.
Competitive Technologies Names Ian Rhodes, CPA As New Chief Financial Officer
PR Newswire - Thu May 22, 8:30AM CDT
FAIRFIELD, Conn., May 22, 2014 /PRNewswire/-- Competitive Technologies, Inc., (OTCQX: CTTC) (CTI), today announced the hiring of Ian Rhodes, CPA, with full responsibility for managing the financial and accounting duties for the Company. Mr. Rhodes will join the executive management team and lead Competitive Technologies' finance and accounting operations from the company's headquarters in Fairfield, CT.
SeeThruEquity 3rd Annual Microcap Investor Conference To Be Held May 28, 2014
ACCESSWIRE - Thu May 22, 8:11AM CDT
Conference Being Held at Convene Grand Central in Midtown
Competitive Tech To Sell Into Europe, The Middle East And North Africa
PR Newswire - Wed Apr 02, 9:15AM CDT
Competitive Technologies, Inc., (OTCQX: CTTC) (CTI), a pain mitigation company, will sell into Europe, the Middle East and North Africa (the "EMENA territory"
effective immediately, in an effort to reestablish the global footprint that was compromised by the signing of the 2012 Amended Distribution and Sales Agreement (the "Amendment" between the inventor and the Company.
East Idaho Interventional Pain Center Now Offering The Calmare® Pain Therapy Device Treatments
PR Newswire - Thu Mar 27, 9:58AM CDT
Patients living with chronic neuropathic and oncologic pain in the Idaho Falls region can now count on a new arsenal in the fight against these conditions. The medical team at East Idaho Interventional Pain Center is now offering a non-invasive approach to their patients with the addition of the Calmare® Pain Therapy Device treatments as part of the suite of procedures offered at the center.
New Study Results: Calmare® Pain Device Therapy May Reduce Chemotherapy-Induced Pain Scores By About 30%
PR Newswire - Tue Mar 25, 9:30AM CDT
The results of a recently published, single-arm clinical study in the Journal of Pain and Palliative Care Pharmacotherapy, (December 2013) demonstrated how a cohort of 39 chronic, chemotherapy- induced peripheral neuropathy (CIPN) patients experienced an average pain score reduction of 31.8% in their level of chronic pain undergoing Calmare® Pain Device therapy - Competitive Technologies, Inc., (OTCQX: CTTC) (CTI) flagship medical product.
Competitive Tech Names Former "Big Pharma" Sales Executive U.S. Division Head of Product Sales
PR Newswire - Wed Mar 05, 8:14AM CST
Competitive Technologies, Inc., (OTCQX: CTTC) (CTI), names Joel Bradus, former "Big Pharma" sales executive, U.S. division head of product sales. Mr. Bradus was appointed with the full responsibility of steering and expanding the Calmare products sales force in the United States.
Pipeline Mosque Inaugurates Africell-Sponsored Minaret
All Africa Global Media - Tue Feb 25, 11:05AM CST
The Pipeline Mosque on Friday inaugurated its new 33.35 meters minaret, reportedly sponsored by Africell GSM Company to the tune of D1 million.
Noka Resources Closes Oversubscribed Second Tranche of Financing
Marketwire - Tue Feb 25, 8:05AM CST
Noka Resources Inc. (TSX VENTURE: NX)(FRANKFURT: 2NK) (the "Company" is pleased to announce that, further to the Company's news release dated February 6, 2014 whereas the Company closed $597,500 of the Non-Brokered Private Placement financing (the "Financing" , the Company has closed the second tranche of the Financing for additional gross proceeds of $536,000, bringing the total amount raised to $1,133,500.
Competitive Tech Slated To Present At The See Thru Equity Winter Microcap Investor Conference
PR Newswire - Wed Feb 05, 2:25PM CST
Competitive Technologies, Inc., (OTCQX: CTTC) (CTI), the pain mitigation company, is slated to present at the SeeThruEquity Winter Microcap Investor Conference on Thursday, February 6, 2014, at 1:30 PM EST.
SeeThruEquity Initiates Coverage on Competitive Technologies (OTCQX:CTTC) with a Speculative Buy Rating - Video Research Alert on InvestmentPitch.com
Thomson Reuters ONE - Thu Jul 03, 9:36AM CDT
Vancouver, BC, July 3, 2014 - New York-based SeeThruEquity has initiated coverage on Competitive Technologies (OTCQX:CTTC). Analyst Brandon Primack gives the company a speculative buy rating, and a target price of $0.79, a premium of 147% to the $0.32 price on June 26th, the day the report was issued.
Judge Ruling Favors Calmare® Pain Therapy Reimbursement In Personal Injury Case Against Allstate Insurance Co.
PR Newswire - Mon Jun 30, 8:32AM CDT
The Calmare® Pain Therapy Device, the flagship product of Competitive Technologies, Inc., (OTCQX: CTTC) (CTI), the pain mitigation company, gained a favorable reimbursement ruling from the New York City Civil Courts in a personal injury case against Allstate Insurance, Co., (Allstate). In the ruling, the Court instructed the insurance giant to reimburse Forest Rehabilitation Medicine P.C. (Forest) for its use of Calmare pain therapy (Calmare) on patients who suffer pain as a result of car accident injuries.
SeeThruEquity Initiates Research Coverage on Competitive Technologies Inc. with Target Price of $0.79
ACCESSWIRE - Thu Jun 26, 8:02AM CDT
New York, NY / ACCESSWIRE / June 26, 2014 / SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced that it has initiated coverage on Competitive Technologies Inc. (OTCQX: CTTC), a pain mitigation company with innovative wound and pain management products and technologies.
Competitive Technologies' Calmare® Pain Therapy Device Featured On The Emmy® Award Winning Program "The Doctors"
PR Newswire - Wed Jun 11, 8:00AM CDT
Competitive Technologies, Inc., (OTCQX: CTTC) (CTI) the pain mitigation company, today announced that the Emmy® award winning TV program "The Doctors" recently featured a medical case involving a young patient living with Complex Regional Pain Syndrome (CRPS) - a long-term chronic disease characterized by severe chronic pain, swelling, and changes in the skin that often worsens over time.
Competitive Tech Slated To Present At The LD MICRO Fourth Invitational Conference
PR Newswire - Mon Jun 02, 9:39AM CDT
Competitive Technologies, Inc., (OTCQX: CTTC) (CTI) the pain mitigation company, will present at LD MICRO's 4th Invitational Conference on Wednesday, June 4, 2014, at 1:30 PM PDT / 4:30 PM EDT.
Competitive Technologies Signs Letter Of Intent To Distribute Calmare With The Mediterranean For Integration And Technology
PR Newswire - Wed May 28, 12:00PM CDT
Competitive Technologies, Inc., (OTCQX: CTTC) (CTI), today announced the signing of a binding letter of intent to distribute and sell the Calmare® Pain Therapy devices (Calmare) exclusively throughout the Middle East and North African territories with The Mediterranean for Integration and Technology (Mediterranean), to distribute and sell Calmare.
Competitive Technologies Names Ian Rhodes, CPA As New Chief Financial Officer
PR Newswire - Thu May 22, 8:30AM CDT
FAIRFIELD, Conn., May 22, 2014 /PRNewswire/-- Competitive Technologies, Inc., (OTCQX: CTTC) (CTI), today announced the hiring of Ian Rhodes, CPA, with full responsibility for managing the financial and accounting duties for the Company. Mr. Rhodes will join the executive management team and lead Competitive Technologies' finance and accounting operations from the company's headquarters in Fairfield, CT.
SeeThruEquity 3rd Annual Microcap Investor Conference To Be Held May 28, 2014
ACCESSWIRE - Thu May 22, 8:11AM CDT
Conference Being Held at Convene Grand Central in Midtown
Competitive Tech To Sell Into Europe, The Middle East And North Africa
PR Newswire - Wed Apr 02, 9:15AM CDT
Competitive Technologies, Inc., (OTCQX: CTTC) (CTI), a pain mitigation company, will sell into Europe, the Middle East and North Africa (the "EMENA territory"
effective immediately, in an effort to reestablish the global footprint that was compromised by the signing of the 2012 Amended Distribution and Sales Agreement (the "Amendment" between the inventor and the Company. East Idaho Interventional Pain Center Now Offering The Calmare® Pain Therapy Device Treatments
PR Newswire - Thu Mar 27, 9:58AM CDT
Patients living with chronic neuropathic and oncologic pain in the Idaho Falls region can now count on a new arsenal in the fight against these conditions. The medical team at East Idaho Interventional Pain Center is now offering a non-invasive approach to their patients with the addition of the Calmare® Pain Therapy Device treatments as part of the suite of procedures offered at the center.
New Study Results: Calmare® Pain Device Therapy May Reduce Chemotherapy-Induced Pain Scores By About 30%
PR Newswire - Tue Mar 25, 9:30AM CDT
The results of a recently published, single-arm clinical study in the Journal of Pain and Palliative Care Pharmacotherapy, (December 2013) demonstrated how a cohort of 39 chronic, chemotherapy- induced peripheral neuropathy (CIPN) patients experienced an average pain score reduction of 31.8% in their level of chronic pain undergoing Calmare® Pain Device therapy - Competitive Technologies, Inc., (OTCQX: CTTC) (CTI) flagship medical product.
Competitive Tech Names Former "Big Pharma" Sales Executive U.S. Division Head of Product Sales
PR Newswire - Wed Mar 05, 8:14AM CST
Competitive Technologies, Inc., (OTCQX: CTTC) (CTI), names Joel Bradus, former "Big Pharma" sales executive, U.S. division head of product sales. Mr. Bradus was appointed with the full responsibility of steering and expanding the Calmare products sales force in the United States.
Pipeline Mosque Inaugurates Africell-Sponsored Minaret
All Africa Global Media - Tue Feb 25, 11:05AM CST
The Pipeline Mosque on Friday inaugurated its new 33.35 meters minaret, reportedly sponsored by Africell GSM Company to the tune of D1 million.
Noka Resources Closes Oversubscribed Second Tranche of Financing
Marketwire - Tue Feb 25, 8:05AM CST
Noka Resources Inc. (TSX VENTURE: NX)(FRANKFURT: 2NK) (the "Company"
is pleased to announce that, further to the Company's news release dated February 6, 2014 whereas the Company closed $597,500 of the Non-Brokered Private Placement financing (the "Financing" , the Company has closed the second tranche of the Financing for additional gross proceeds of $536,000, bringing the total amount raised to $1,133,500. Competitive Tech Slated To Present At The See Thru Equity Winter Microcap Investor Conference
PR Newswire - Wed Feb 05, 2:25PM CST
Competitive Technologies, Inc., (OTCQX: CTTC) (CTI), the pain mitigation company, is slated to present at the SeeThruEquity Winter Microcap Investor Conference on Thursday, February 6, 2014, at 1:30 PM EST.
